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INTRODUCTION 
According to WHO about 265 000 estimated deaths that occur every year 
are caused by burns. Of which almost half occur in the WHO South-East Asia 
Region. There are about 1 million burn cases in India every year. Timely care 
and management of the burn patients are required to save the life of the burn 
patients.1 
              In burn patients, bacterial invasion is not unexpected. It has been 
reported that, despite antibiotics without topical therapy, burn wound can 
contain up to 100 million organisms per gram of tissue after 2 days of injury. 
Infections are found to be the most common cause of death in those who survive 
the initial treatment. It is estimated that about 65% of the deaths in burn patients 
is caused by septicaemia. The most common organisms isolated are 
Pseudomonas aeuroginosa (in 29% cases) & Klebsiella sp. (in 28% cases), 
isolated either singly or in combination.1  
 The study of recent decades had found that the platelet changes have 
close relationship with diseases & drugs. Early detection of the deterioration of 
the patient and prompt treatment will help in saving the life of the patient. This 
study aims in finding the correlation between the post burn septicemia and 
platelet count in predicting the prognosis. 
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AIM OF THE STUDY 
1. To evaluate platelet count as a prognostic indicator in burn septicaemia.  
2. To find the correlation of other factors that causes platelet count changes 
in severe burn patients. 
3. To identify the most common organisms involved in burn septicaemia.  
4. Correlation of body surface area burnt to the platelet levels. 
5. To find  age groups involved in the burn injury. 
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REVIEW OF LITERATURE 
HISTORY 
             Documented burns and their management go as far as 3500 yrs ago, in 
cave paintings. Egyptians use salve of resin and honey for treating burns as far 
as 1500 BC which has been documented in papyrus. Chinese have been using 
tinctures and tea leaves extract in 600 BC. In first century AD Celsus mentioned 
using wine and myrrh in burns dressings for its bacteriostatic properties. The 
importance of protecting the burns patients from bacterial invasion has thus 
been recognised even in ancient times.2  
                 Through various disasters in our past, we have learned a great deal in 
management of burns patients. 
              Recognising the infection and sepsis early and their prevention and 
management has been a major advancement in reducing the mortality in the 
burn patients. One of the first topical antimicrobials, sodium hypochlorite 
(NaClO) first discovered in 18th century, was used extensively in    World War I  
by Henry D Dakin, saving the life of many soldiers.2 
             In world War II Germans pioneered in the usage of Mafenide acetate for 
treating the open wound, which was later adopted to treating the burns by 
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Robert Lindberg and John Moncrief  as Mafenide acetate can penetrate 3rd 
degree eschar.2 
              Trumen G. Blocker Jr. was the first to demonstrate the importance of 
multi disciplinary approach after a major disaster in 1947 when two freighters 
loaded with ammonium nitrate fertilizer exploded in Texas docks, injuring more 
than 3000 and killing 560 people. Truman and Virginia Blocker are renowned 
for their research in advancing burn care. Most of their principles laid 
foundation for burns management even today.2 
             Between 1942 and 1952 – Shock, sepsis & multiorgan failure caused 
upto 50% mortality in children with TBSA of about 50%. This was reduced to a 
grest deal by removing the nidus of infection i.e the burnt and dead tissue. In 
early 1940s removal of burn eschar and immediate closure of the wound was 
recognized as the most efficient therapy to improve the mortality rate. At 
Birmingham hospital, Douglas Jackson and colleagues advanced a technique in 
which fascial excision and grafting was done in upto 65% TBSA found to have 
reduced the sepsis and mortality in Burns patients.2 
          The evolution of burn treatments over the past 50 years has been 
extremely productive. The mortality rates have fallen significantly thanks to the 
early resuscitation and early detection of septicaemia. Of the various modalities 
used in early detection platelet levels, being used as an indicator is gaining 
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popularity. There are many studies done both in India and abroad to validate 
this theory. We try to find the validity of this concept in our study.   
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ANATOMY 
The largest organ in our body is skin, making up to 16% of bodyweight.3 
Its   surface area is 1.8 m2. It performs many functions, of which forming a 
physical barrier to the surroundings and providing protection against ultraviolet 
radiation, micro-organisms, toxic agents, mechanical insults, etc., is the most 
important. Skin has 3 layers. They are epidermis - the superficial layer, dermis – 
the middle layer and subcutis – the deeper layer. The derivatives of the skin are 
- nails, hair, sebaceous, apocrine and sweat glands. It is a dynamic organ. There 
is a constant state of change, the cells in the outer layers are continuously shed 
& they are replaced by the inner cells which moves up towards the surface.4 
Skin anatomy  
 The outer most layer is epidermis. It serves as chemical & physical 
barrier between the environment & body.  
 Dermis is deeper layer, providing the structural support to skin. 
 Subcutis or hypodermis is below dermis. It is a loose connective tissue 
layer. It is a fat depot.  
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Epidermis : 
                Epidermis is made of stratified squamous epithelium. The main cells 
of epidermis are keratinocytes. It synthesise keratin. Desmosomes bridge the 
keratinocytes. The different keratin maturation stages forms four separate layers 
in the epidermis. Thickness of the epidermis varies. It is 0.05 mm in eyelids & 
up to 0.8±1.5 mm in the soles of the palms & feet. 4  
The 4 layers from superficial to deep are:  
 stratum corneum is the horny layer 
 stratum granulosum is thegranular cell layer 
 stratum spinosum is the spinous or prickle cell layer 
 stratum basale  is the basal or germinativum cell layer  
The stratum lucidum is an additional thin layer made of translucent cells. 
It is usually seen in thick epidermis. It is a transitional layer between the stratum 
corneum and stratum granulosum. It is absent in thin epidermis. Stratum 
granulosum & stratum spinosum together form the Malphigian layer.4 
The thickness of the skin varies according to the age of the individual and 
the anatomical location.  
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2. LAYERS OF SKIN 
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Dermoepidermal junction (basement membrane):  
             It is made of 2 layers. Papillary dermis is formed by dermal papillae 
from which projects perpendicular to the skin surface. By diffusion at the 
dermoepidermal junction the epidermis disposes waste & gets nutrients via 
diffusion at this junction.6 
Dermis  
           The thickness of the dermis varies from 3 mm on the back, soles and 
palm to 0.6 mm in the eyelids. It is made of a supportive & tough cell matrix. It 
is made of two layers. They are thin papillary layer above & thick reticular layer 
bellow.8 
       The dermis is composed of collagen producing fibroblasts, structural 
proteoglycans, elastin & immunocompetent macrophages and mast cells. 70% 
of dermis is made of collagen fibres giving its strength & toughness. Elastin 
maintains normal elasticity & fexibility. The viscosity & hydration is 
maintained by proteoglycans. 
Dermal vasculature, nervous cells, lymphatics, hair roots, sweat glands & 
small amounts of striated muscle lies in the dermis. 
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Subcutis  
It is made up of fat & loose connective tissue. In the abdomen, it can be 
3.5 cm thick.8  
Blood and lymphatic vessels  
Branches from subcutis artery form the superficial artery plexus at the 
papillary & reticular dermal boundary. This plexus branches to form capillary 
loops at the dermal papillae. Constriction & dilation of this capillary loops helps 
in thermoregulation. Lymphatic drainage occurs by lymphatic meshes which 
originates in the papillae & feeds into a larger lymphatic system which drains 
into a regional lymph node.4  
Nerve supply  
       Free sensory nerve endings in dermis detects temperature & pain. There are 
specialised corpuscular receptors in the dermis like Meissner's corpuscles that 
senses touch & Pacinian corpuscles that senses pressure & vibration. The motor 
innervation of skin is by the autonomic nerve fibres. Blood vessels, apocrine 
glands & hair erector muscles are innervated by adrenergic nerve fibres. While 
eccrine sweat glands are innervated by cholinergic nerve fibres. The sebaceous 
glands are regulated by endocrine system.4 
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FUNCTIONS OF SKIN 
The skin is an active complex organ, it does various physiological 
functions. The list of some are summarised below. 
 Barrier function and skin desquamation  
As keratinocytes move up towards stratum corneum, it clumps proteins 
into granules in stratum granulosum. Fillagrin that complexes with keratin fills 
these granules. Enzymes break down the keratin-fillagrin complex as 
degenerating keratocytes move up. Keratin remains inside & fillagrin forms 
outside cornecytes.8 
As the skin’s moisture content reduces, specific proteolytic enzymes 
breakdown fillagrin into free amino acids. This fillagrin breakdown occurs to 
control osmotic pressure & amount of the water it holds only when the skin is 
dry. Stratum corneum contains around of 30% water in healthy skin. Free amino 
acids, urea, salts & lactic acid are known as `natural moisturising factors' 
(NMF).It is responsible for maintaining a moist & pliable skin by attracting and 
holding water.8 
 UV protection  
Melanocytes & melanin have an important role as skin's barrier by 
protecting from UV radiation. In inner layers of epidermis, melanin 
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granules form a protective shield around nuclei of the keratinocytes. They 
are evenly distributed in outer layers of epidermis. By absorbing UV 
radiation, it protects the nuclei of the cell from the DNA damage.8  
 Thermoregulation  
By evaporation of sweat from its surface & by changes in flow of blood 
in the cutaneous vascular system, skin plays a major role in maintaining 
body temperature.8 
 Immunological surveillance  
Skin plays a significant role in immunological surveillance. It has all 
elements of the cellular immunity, except the B cells 2.8  
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Table 1 : SKIN – PROTECTIVE BARRIER 
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BURNS 
 A burn is injury to skin or flesh caused by the heat, chemicals, electricity, 
friction, or the radiation.9,12       
Cause 
Variety of sources that cause burns can be classified as   
 Thermal i.e. Heat related 
 Electrical 
 Radiation 
 Chemical 
                 In about 6% of burns cases, inhalational injury can be caused by 
these sources. Burn injuries are more common in poor. Cooking on floor or with 
open fire are Specific risk factors in developing world.10,14 
Thermal  
      Thermal injury is the most common cause of burns. They can be due to 
either fire, hot liquid, or contact burns. Fire and hot liquid is the cause of 
majority of the thermal injury. Exposures to hot gases or liquids causes scalding 
this commonly occurs due to exposure to high temperature tap water, steam, 
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cooking oil or hot drinks. In children under 5yrs. scald injuries are common.24 
Scald are usually 1st or 2nd degree burns. 3rd degree burns in scalds occurs 
with prolonged contact. During holidays fireworks are common 
cause in our countries for adolescent males.10 
Chemical  
It causes 2 to 11% of burns. It contributes to as high as 30% of burns and 
burns related deaths. Over 25000 substances can cause chemical burns. 
Most of them are a strong acid (26%) or a strong base (55%). Most of the 
chemical burns deaths are secondary to ingestion. Sulfuric acid found in toilet 
cleaners halogenated hydrocarbons found in paint – remover & 
sodium hypochlorite found in bleach are the common agents.17  
Formic acid cause the breakdown RBC.Hydrofluoric acid cause burns 
that are deep but may not be symptomatic until some time after the exposure. 
Electrical  
They can be either  
 low voltage - less than1000 volts,   
 high voltage - more than 1000 volts, 
 flash burns due to electric arc. 
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Lighting may also cause electrical burns. Risk factors for lightning 
striking include outdoor activities like mountain climbing, golfing &field sports. 
It causes 10% mortality. The common causes of electrical burns in children 
are electrical cords (60%) then by electrical outlets (14%). 
Electrical injuries usually result in burns but they can also cause 
dislocations & fractures secondary to muscle contractions or due to blunt 
force trauma. Cardiac arrhythmias may result from contact with high or low 
voltage. 
Radiation  
Radiation burns are caused by prolonged exposure to UV light (from 
tanning booths, the sun or arc welding) or due to  ionizing radiation (radioactive 
fallout or X rays or from radiation therapy.) Sun exposure is the 
most  common  cause for  radiation  burns.18  
It is the most common cause for superficial burns. Based on skin type, 
there are variations in how easily one can get sunburn.  
Effects due to ionizing radiation depends on amount of radiation exposure 
3 Gy causes hair loss, 10 Gy causes redness, 20 Gy causes wet 
skin peeling and 30 Gy causes necrosis. Redness may not appear for  
some time after the exposure.  
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Microwave burn are due to thermal heating by the microwaves. 
While even exposures to 2 seconds can cause injury, it is relatively uncommon 
occurrence. 
Radiation burns are managed the same like other burns.18  
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PATHOPHYSIOLOGY 
At 44 °C (111 °F) proteins starts losing its shape & starts to break down. 
It causes tissue damage. The disruption of functioning of the skin causes most 
its direct effects.19  
It includes skin's sensation disruption, loss of water retention properties 
& ability maintain body temperature. Cell membrane disruption causes  the loss 
of  K+  ions to extracellular space & to take up water & sodium.  
There is significant inflammatory response in large burns. (i.e. More than 30% 
of TBSA). This results in tissue edema.19  
This results in volume loss (significant plasma loss) increasing the 
concentration of the blood. Poor blood flow to the organs results in multi organ 
failure.  
Levels of cortisol & catecholamines are increased and can cause hyper 
metabolic state for long duration.    
There is associated poor immune function, increased metabolism, cardiac 
output & heart rate.19 
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JACKSON’S ZONES 
              Burn injury produces coagulative necrosis. The severity of the burn 
necrosis is severe at the centre and is progressively less severe towards the 
periphery. Jackson described 3 zones of injury in 1953 which remains in use till 
date.  
The three zones of injury47 are 
1. Zone of Coagulation. 
2. Zone of stasis.  
3. Zone of hyperaemia. 
Pic. 3: Jackson’s Zones 
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Zone of coagulation 
 It is located at the centre.  
 It has no viable cells. 
Zone of Stasis  
 It is the intermediate zone. 
 It is a zone of capillary vasoconstriction & ischemia. 
 It is a mix of non-viable & viable cells. 
 It represents the zone at risk. With proper management this zone can be 
salvaged. 
Zone of hyperaemia 
 It is a zone of vasodilatation and viable cells. 
 This zone usually recovers completely if no complications occur. 
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Depth 
Burns are classified by depth, mechanism of injury, extent & associated 
injuries classification by depth is the commonly used classification. Depth of the 
burn is determined via examination. It is difficult to exactly determine depth of 
the burn on a first examination.20 
 It patient complains of headache or dizziness, Cyanide poisoning and CO 
poisoning should be ruled out.21 
Pic. 4: Degree of Burns 
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Size 
 Size of burn area is measured in percentage of the total body surface 
area that is affected by full thickness or partial thickness burns. The Wallace 
rule of nines, person's palm size based estimations and Lund and Browder chart 
are few methods to determine the total body surface area (TBSA), rule of 
9's is accurate only in people more than 16 yrs of age. Lund & Browder 
charts are accurate which take different body proportions in children & adults 
into account. A person's handprint (including the fingers & palm) is 1% 
approx of their   TBSA.21 
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Pic. 6: % of TBSA calculation 
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MANAGEMENT 
 It begins with the assessment & stabilization of person's airway, 
breathing and circulation. Early intubation is required for inhalation injury 
before giving care to the the burn wound. Extensive burns patients can be 
wrapped with clean sheets to get to the hospital. Those who not immunized 
within last 5 years with tetanus toxoid, booster should be given. Early feeding 
is important with major burns.24 
Intravenous fluids 
          Fluid resuscitation & monitoring should begin as early as possible 
especially in adults with greater than 15% burns & in children with greater than 
10 % - 20% burns. The fluid requirement for the first day can be calculated by 
Parkland formula. It is based on affected individual's weight & TBSA. In the 
first 8 hrs, half of the calculated requirement is admistered & following 16 
hours the rest is administered. Time should be calculated from when the burn 
injury occurred & should not be calculated from when fluid resuscitation began. 
More fluid is required for children & those with inhalation injuries.  
The formulas can be used only as a guide. The infusions should be 
titrated to urinary output of more than 30  mL pe r hou r  i n  adul t s  and  
more  than  l  m L pe r k i lo g ram pe r hour in children & for mean arterial 
pressure of more than 60 mmHg.26 
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RL is the solution routinely used but it is not superior to NS. 
Crystalloids are as good as colloids. But it is not recommended as colloids are 
expensive. Blood transfusions are recommended when Hb level falls less than 
6 - 8  g/dL.25 
Wound care 
Early cooling will reduce depth & pain due to burn, but overcooling 
can cause hypothermia. Cool water of 10 to 25 °C (50.0 to 77.0 °F) can be 
used. Ice water should not be used as it can worsen injury. Extensive 
irrigation is required for chemical burns. Important aspects of wound 
care are cleaning & removing the dead tissue & application of dressings. Re-
evaluation of 2nd degree burns after two days.27 1st degree burns can be 
managed without dressings. Topical antibiotics are usually recommended. 
Medications 
 Burns are painful, different options can be used for 
management of pain. They are simple analgesics (NSAID's) & opioids. 
Benzodiazepines can be used to help with anxiety. Massage, antihistamines 
and transcutaneous nerve stimulation are used to help with itching during 
the healing. Antihistamines are effective only in 20% of people for th i s  
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purpo se .  Gabapent in  can be  u sed  in  those  no t impro vi ng  with 
antihistamines. 
Lot of contradic tions exists on how the antib io t ics should be 
used.  2008 guidelines does not recommend routine use of antibiotics due to 
risk of fungal infections & antibiotic resistance. Erythropoietin is not effective 
to treat anaemia in burn patients. Calcium gluconate is the specific antidote 
for burns caused by hydro fluoric acid.  
rhG (Recombinant human growth hormone) in extensive burns involving 
greater than 40% TBS A can speed healing.30 
Surgery 
Wounds that require surgical closure with flaps or skin grafts are 
done as early as possible. Burns that are circumferential especially in the 
chest or limbs may need immediate surgical release an escharotomy to 
prevent and to help in treating problems with ventilation or distal 
circulation. Electrical burns require fasciotomies. 
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Alternative medicine 
Aloe vera might be useful in reducing pain and can improve healing 
time.34   
Honey is used from ancient times to help with wound healing. It can be 
beneficial in 1st & 2nd degree burns.33 
Prognosis in Burns  
Female sex , la rge burns & old age are  worse prognostic  
factors. Smoke inhalation injury & other significant injuries like fracture 
bones & co-morbidities also influence prognosis. 
 Baux score can been used to find the prognosis in major burns. But it is 
no longer accurate due to improvement in care. This score is calculated by 
adding the TBS A burnt & age of patient. It is taken it to be more or 
less equal to the risk of death. 
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Table 3: AMERICAN BURN ASSOCIATION SEVERITY 
CLASSIFICATION 
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POST-BURN INFECTION & SEPSIS 
Definitions 35 
 Bacteraemia:  The transient presence of bacteria or other 
microorganisms in the blood.  
 Septicaemia:  The invasion of the blood stream by pathologic microbes 
from a focus of infection or a locus minoris resistentiae and an active 
proliferation of these microbes accompanied by hyperthermia, 
hypothermia and/or prostration.  Frequently, it is diagnosed clinically by 
the presence of any 3 of the cardinal signs:  obtundation, 
hyperventilation, ileus, thrombocytopenia, hyperglycaemia, leucocytosis 
or leukopenia. 
 Colonization:  The mere presence of bacteria, establishment of a colony 
with no evidence of invasion into viable tissue. 
   A common and serious complication after burns is infection. Despite 
antimicrobial therapies, 60% of deaths in the burn patients are due to sepsis. 
Sepsis in burns patients are due to pyelonephritis, bronchopneumonia, invasive 
wound infection or thrombophlebitis.  Microbial colonization is established 
within first week, primarily from endogenous sources.  Loss of the epithelial 
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barrier promotes infection, other factors are malnutrition due to the hyper 
metabolic response, & generalized post-burn immunosuppression. 
    Immunoglobulin's, complement levels & fibronectin are reduced in burn 
patients. Also ability for opsonization, phagocytosis, chemotaxis & killing 
function of neutrophils, macrophages & monocytes are impaired. Impairment of 
cellular immune response also occurs. There are reductions of T-cell & NK cell 
cytotoxicity, interleukin-2 (Il-2) production & HSR (helper to suppressor T-cell 
ration) reduction.  
  Though control of infection in burn wound care is not our initial priority, 
the subsequent survival in burns patient depends on it. Within five days post-
burn, the avascular burn eschar is colonized even when treated with the 
antimicrobial drugs.  The risk of the wound infection is great, when the bacteria 
in the wound is more than 105 microorganisms per gram of tissue and when 
wound closure is delayed & when there is bad skin graft survival. When 
immune defences of the host are exceeded by bacterial density, it results in 
invasive burn sepsis.35 
  Control of bacteraemia & preventing the viable tissue desiccation are the 
goals of local wound management. This is achieved by using biological 
dressings and/or using the topical antimicrobial agents.36  It is not possible to  
keep a burn wound free of bacteria.   
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When the count is less than 103 organisms per gram, they are mostly not 
invasive & have high skin graft survival i.e.  >90%.36 
    Antimicrobial therapy is based on routine bacterial surveillance by tri-
weekly sputum, wound & urine cultures. Punch biopsies for every 18% BSA of 
burn can be done for wound monitoring till wound healing occurs. A qualitative 
surface swab is inferior when compared with wound biopsy in determining the 
pathogens. Organisms are identified & antibiotic sensitivity is obtained within 2 
days. Topical antimicrobials susceptibilities can be tested by agar diffusion 
assays.  When quantitative biopsies shows microbial density of more than 
103 organisms per gm, the topical therapy should be changed. Wound infection 
can be confirmed by histological evidence for invasion of the tissues or by 
clinical sepsis. Wound is excised & systemic antibiotics instituted for wound 
infection. 
   It is difficult to distinguish sepsis in burn patients from the routine 
hypothermic, hyper metabolic, hyper dynamic post-burn state. The blood 
cultures are usually negative.  The degree of infection and fever spikes are not 
proportional.  
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Diagnosis of sepsis is made clinically by meeting at least three of the following 
criteria: 
 burn wound infection (more than 105 organisms per gm tissue) with 
clinical or histological evidence of invasion 
  unexplained hypoxia, acidosis or hyper/hypoglycaemia 
  leukocytosis or -penia ( more than 20,000 or less than 3,000) 
  thrombocytopenia ( less than 50,000) or falling rapidly    
 positive blood cultures 
  hyper/hypothermia (more than 39°C or less than 36.5°C) 
  progressive pulmonary dysfunction or renal failure  
 altered mental status 
 documented catheter or pulmonary infection 
  prolonged paralytic ileus    
 Local evidence for invasive wound infection is: 
 conversion of wounds to full-thickness 
  rapid eschar separation 
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 patches of black or brown wound discoloration  
 punctuate hemorrhagic sub-eschar lesions 
 spreading peri-wound erythema  
 ecthyma gangrenosum - black or violaceous lesions in unburned tissue  
   Antibiotics are used are based on the following definitions: 
 Prophylactic - A precautionary or preventative measure to prevent the 
disease spread & preserve  health. 
 Perioperative - It is the systemic antibiotic administration as protective 
measure during surgical intervention. It can also be considered 
prophylaxis. The time frame for its administration is short-lived & it is 
limited to up to three doses, based on the interventional procedure. 
 Therapeutic – Administering the antibiotics for the treatment of 
infection.  Based on the infection, it may continue for many days. 
Systemic antibiotics are administered for burns sepsis should be 
continued for minimum of three days after the sepsis has resolved. When the 
wounds appear clean, then other sources like the peripheral veins, lungs, & 
kidney must be suspected.   
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When confirmed organism or site is absent, antibiotic is selected based on 
the routine surveillance cultures. Empirical antibiotic agent should be based on 
the sensitivities of burn facility's endogenous organisms. Routine perioperative 
antibiotics are also based on the same. The same antibiotic drugs are continued 
post-operatively till the identification of quantitative bacterial load in the 
excision wound biopsies. 
Blood Cultures   
The best time for collecting the specimen will be before temperature 
spikes. Blood culture is essential for determining septic episodes. Temperatures 
of above 39.5 C is our body's method of cleansing our blood stream.  Most 
bacteria's cannot survive a prolonged exposure to temperature of more than  
39.5 C.  Blood culture bottle should not be contaminated. Site selected should 
be aseptically & meticulously cleansed before the collection of specimen.  
Urinary Tract Infection  -  If  U.T.I. is the suspected cause for sepsis, 
urine should be collected aseptically. On the request slip appropriate comments 
should be written. (e.g.:-  Temp. 39.8, catheterized, clean catch, etc.) 
Upper Respiratory Infection  - If U.R.I. is evident or suspected from an x-
ray, clinical signs, bronchial washings or sputum, it is  essential to identify the 
agent. Usually, organisms responsible for lung infection mostly correlate with 
organisms in the wound. 
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TOPICAL ANTIMICROBIALS 
Topical Antimicrobials Currently used drugs are silver sulfadiazine, 0.5% 
silver nitrate, mefenide acetate, bacitracin or polymyxin B, Mycostatin & 
mupirocin. There is nothing called “totally effective single agent”. Each have 
their advantages & disadvantages.  All the agents can increase metabolic rate & 
affect wound healing.27 
Silver sulfadiazine 
    Silver sulfadiazine is the routinely used topical antimicrobial. It covers a 
broad spectrum of microbes includes gram +ve bacteria, many gram -ve bacteria, 
& some fungus. Its antimicrobial action is derived from its silver & sulpha 
moieties. Plasmid mediated resistance is found in some gram -ve organisms 
e.g.Pseudomonas species. It does not hinder epithelialisation like silver nitrate 
or mafenide. Although it hampers the contraction of fibroblasts.  Moreover, 
silver sulfadiazine has good patient acceptance as it  is painless on application & 
it is easy to use with/without dressing.  Though it rarely causes allergy, transient 
leukopenia can develop in 3 to 5 days following their continued use. It is 
secondary to circulating white blood cells margination.  This is usually a 
harmless leukopenia. It requires observation without cessation of treatment. But 
when the white blood cell count falls to less than 3000, then drug is withheld  
till the WBC count returns to 4000-5000 range or more.27  
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Mafenide Acetate 
11.2% Mafenide acetate is an old but effective topical antimicrobial 
agent. It is effective against a broad spectrum of microbes, which includes silver 
sulfadiazine resistant Enterococci & Pseudomonas, but it has lower antifungal 
properties. The mechanism of action of mafenide is not clear. It is believed to be 
due to its water soluble sulpha moiety. Mafenide is toxic to fibroblasts & 
epithelial cells. Mafenide can penetrate through the eschar. Because of this 
property mafenide is used on infected or dirty burn wounds, electrical burns, & 
to prevent chondritis in burned ears. Mafenide causes a manful sensation for 
several minutes following its application, earning its nickname 'white 
lightning'. It can cause allergic skin rashes. Mafenide causes systemic metabolic 
acidosis, bicarbonate wasting in kidneys, hyper chloremia & compensatory 
hyperventilation by its carbonic anhydrase inhibition action. To protect against 
metabolic abnormalities serum electrolyte levels are sequentially followed & 
abnormal values are treated with intravenous replacements. Alternatively, its 
topical application can be limited to less than 20% of  BSA at any one time. The 
sites are rotated every 2 hours till all the burn injury has been treated. Silver 
sulfadiazine & mafenide can be alternated on highly contaminated wounds to 
form a 'pulse therapy'. 
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0.5% Silver Nitrate 
0.5% silver nitrate is a non-penetrating, painless, broad spectrum 
antimicrobial agent. It requires multiple daily applications on burn dressings. 
It is messy and staining. It is a hypotonic solution; so hyponatremia, 
hypokalemia & electrolyte leeching are the most common side-
effects. Methemoglobinemia is a very rare complication of its use. Silver 
nitrate is used in patients allergic to mafenide or silver sulfadiazine & in 
treatment for toxic epidermal necrolysis syndrome.  
   Petroleum based antimicrobial ointments like polymyxin B & 
bacitracin are painless, clear on application & thus allow easy wound 
observation. They are commonly used in the treatment of healing donor sites, 
small partial-thickness burns, facial burns & graft sites. Povidone iodine 
ointment has broad antimicrobial activity, including fungi, bacteria & some 
viruses. Mupirocin has improved activity towards gram+ve bacteria, 
especially (MRSA) methicillin resistant Staphylococcus.  
    The combination of mycostatin powder or ointment with the other 
topical agents will reduce the fungal super infection incidence & improve 
antimicrobial action.  Mafenide & mycostatin will inactivate each other and 
hence should not be used in combination.  In addition, alimentary fungal 
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overgrowth can be reduced by mycostatin given orally at 5-15 ml TDS 
dosage.  
    Topical antimicrobials are usually with closed dressings. It provides 
for greater comfort & less desiccation when compared with open 
technique.  The topical antimicrobials are spread on the wound & covered 
with protective gauze dressing & with elastic compressive wrap. Dressing is 
changed every 9 to 12 hrs. During dressing changes, wounds are cleaned 
gently prior to re-application of the dressing. In suspicious or contaminated 
areas, dilute Dakin's solution (phosphate buffered 0.25% hypochlorite 
solution) or antimicrobial soap are used to wash the wounds. This irrigation 
reduces hyper metabolic squeal & septic episodes. This improves subsequent 
graft survival. 
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BIOLOGICAL DRESSING 
The topical antimicrobials affect wound healing and alter metabolic 
rate. They need re-application & daily maintenance. Direct toxic or 
antimicrobial properties are absent in biological dressings, but it creates a 
wound environment that diminishes bacterial proliferation, prevents 
desiccation, reduces loss of protein, heat, water & red blood cells. It promotes 
rapid wound healing. It can also reduce the burn wound pain. These materials 
can be synthetic or organic in origin. The key is a good wound 
adherence. Organic materials are skin allograft, xenograft (pigskin) & human 
amnion.  Op-site, Biobrane and Omiderm are examples of synthetic covers.37 
  Gold standard for temporarily covering the clean open wound is the 
fresh skin allograft (also called homograft). This allograft makes an 
environmental 'seal' of burn wound at graft-wound interface & will improve 
host immune defences. Living relatives or fresh cadavers within 18 hrs of 
death (assures the viable skin cells in the graft) are used in allogenous human 
skin graft. This graft re-vascularise once it is adherent to the wound.  The 
best temporary closure is provided by allograft.37 
     Due to the antigenicity is retained by the langerhans cells of the 
transplanted epidermis & the allograft, skin be rejected in 8 to 15 days in 
normal patients. Tolerance of allograft increases up to several weeks due to 
immunosuppression in the major burn patients. This allows prolonged 
temporary wound closure. The allograft promotes maturation & angiogenesis 
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in the underlying granulation tissue. Good allograft 'take' indicates 
subsequent good skin autograft take. 
 
 
     
 
 
 
 
Pic. 7: Skin Graft Thickness  
Fresh skin allograft has limited supply, a high price tag, short shelf life 
of 2-3 weeks & need refrigerated storage.  Freezing or lyophilisation 
improves the shelf life. But this diminishes graft adherence, cell viability & 
protective function of allograft. Fresh skin allograft must be used only in 
clean wounds in which graft 'take' is anticipated.37 
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Pic. 8: Split Skin Grafting Done at Burn Site 
 Amnion will be readily available from delivery suite. It is 
inexpensive. But it adheres poorly to burns wound. So it should be covered 
by occlusive dressing. Amniotic coverage use in burns has become 
disfavoured though it promotes angiogenesis & increases wound capillary 
density.37  
      Synthetic biological dressings can provide wound protection and 
prevent wound desiccation & contamination. It increases the wound healing, 
and also reduces patient’s discomfort. Intervening serum or necrotic tissue 
can results in infection. So good wound adherence is required for success. It 
is essential to have diligence in application. When it is used to cover partial-
thickness clean wounds, this dressing detaches as reepithelialisation & 
keratinisation occurs underneath.37 
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   Biobrane is a bi-laminate, synthetic membrane with an inner collagen 
nylon matrix & an outer silicone semi-permeable layer.  The granulation 
tissue in grows into inner Biobrane layer which increases its adherence. It is 
elastic and transparent this allows fuller range of movement, easy drape 
ability & easy wound inspection. It is suited for partial-thickness burns, 
donor sites & excised/clean wounds before grafting.  Biobrane gloves used in 
partial-thickness burns in hand will reduce discomfort & will increase motion. 
This allows aggressive earlier physiotherapy. Biobrane is also used in 
covering skin grafts, this prevents slipping & desiccation. It lacks inherent 
antimicrobial properties & it is expensive.  Wound infections are common 
with biobrane. 
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PLATELETS 
Platelet is a blood component, first discovered in 1841 by George 
Gulliver by using a compound microscope. Platelets along with coagulation 
factors are responsible for blood haemostasis by clogging blood vessel 
injuries. Platelets ( fragments of cytoplasm derived from the megakaryocytes) 
have no nucleus. The inactivated platelets are lens shaped structures 
(Biconvex discoid). It measures 2-3µm in its greatest dimension.40 Only 
mammals have platelets. All the other Classes in Animal Kingdom have 
intact mononuclear cells circulating as thrombocytes.38 
 In a blood smear after staining, platelets appears as an dark purple 
spots, which is about 20% of the diameter of RBC.   
The major function of the platelets is helping in haemostasis. 
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Primary haemostasis 
Formation of platelet plug   
Secondary haemostasis  
 Coagulation cascade activation resulting in fibrin deposition and cross 
linking.  
            This is an overlapping process. It is a spectrum having the 
predominantly platelet plug (white clot) in one end and the predominantly 
fibrin clot (red clot) in the other. 
Platelets & Inflammation  
 Platelets are deployed rapidly to sites of infection or injury. They 
modulate inflammation by secreting chemokines, cytokines and other 
mediators of inflammation. They also interact with leukocytes. They also 
secrete PDGF ( platelet derived growth factor).  
PLATELET COUNT    
          Platelets can be measured manually by using a haemocytometer. 
Alternatively an automated platelet analyzer like Coulter counters which 
works on the principal of electrical impedance.41 The normal range is 
about 1.5 to 4 lakhs per cubic millimetre 42 ( 150 - 400 × 109 per litre ).  
      Men have a slightly higher mean value when compared with women.  
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STRUCTURE 
Structurally the platelet is divided into 4 zones,41 from periphery to centre  
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Pic. 9: HEMATOPOISIS 
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PLATELETS AND SEPTICAEMIA 
A number of abnormalities of blood coagulation have been described 
in association with septicaemia, but the frequent occurrence of isolated 
thrombocytopenia has been emphasized only recently. Possibility of 
septicaemia can be alerted by thrombocytopenia which occurs early in the 
course. This observation was emphasized in 1966 in adults & subsequently in 
children by Corrigan. The mechanism of thrombocytopenia in septicaemia is 
uncertain. Its rapid onset suggests that there is increased platelet destruction, 
a mechanism that is supported by the results of platelet survival studies 
reported by others previously.44  
It is also likely that some impairment of platelet production occurs in 
patients with septicaemia. It has been suggested that the increased rate of 
platelet destruction in patients with septicaemia may result from either overt 
or possible subclinical DIC. It is also possible that thrombocytopenia is a 
more sensitive indicator of in vivo thrombin action than are results of the 
protein coagulation assays. However, in vitro tests suggest that thrombin 
formed in solution reacts more rapidly with plasma fibrinogen than with 
platelet receptors. While the FPA was mildly elevated in many of the patients, 
it was similarly elevated in those patients with normal platelet counts. It 
seems most unlikely that increased thrombin action by itself accounts for the 
62 
 
decreased platelet counts, since similar or higher FPA levels occur in patients 
with thromboembolism and other diseases who have platelet counts in the 
normal range. In a recent study of FPA levels and platelet counts in patients 
who received intrauterine infusion of hypertonic saline for termination of 
pregnancy, and in whom the decrease in platelet count may have more 
directly reflected increased thrombin action, a mean FPA level of 18 
pmole/ml was associated with a mean drop in platelet count. It is, therefore, 
likely that the thrombocytopenia (50,000-l50,000/ml) in this group of patients 
with septicaemia is contributed to by mechanisms other than intravascular 
coagulation.  
          Endothelial cell damage occurs in endotoxin-treated animals and may 
be a contributing factor to thrombocytopenia in septicaemia patients by 
promoting platelet adherence to sub endothelium. The low levels of factor 
XII found in many septicaemias may reflect activation and clearance of 
factor XII by exposed sub endothelium or activation of factor XII by 
endotoxin. However, it is noteworthy that it occurred both in patients with 
gram-positive and gram-negative septicaemia. It is recently reported that 
many septicaemia patients with thrombocytopenia have a decrease in level of 
platelet associated IgG. We have postulated that in septicaemia, this may 
reflect the presence of immune complexes, comprised of bacterial products 
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and their antibodies, which adhere to platelets and result in their premature 
destruction.  
           In a study by Y Durmaz, E Guclu & O Karabay, in sepsis patients 
platelet count was lower when compared with control group. This difference 
was very small. But PDW was significantly different between survivors & 
non-survivors (p=0.001). Thus platelet index is an important lab finding that 
can be used in the diagnosis of sepsis. In sepsis patients with greater than 18 % 
PDW have a greater risk of death. Hence PDW can be used in predicting 
mortality in sepsis patients. In this study we try to find the correlation 
between the platelet levels and septicaemia and its use in predicting the 
outcome of the patient.47 
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INHALATION INJURY 
 As improvements were made to reduce mortality due to septicaemia 
and wound infection, inhalation injury became a major cause of mortality. 
According to National Burn Repository 2012 Report, there is an increase in 
the likelihood of death by 16 times due to inhalation injury. Nearly up to 45% 
are limited to upper respiratory tract. Only in about 5% a direct parenchyma 
injury is present leading to early acute respiratory death.46 
Inhalation injury was widely identified with history of the incident. In 
1972 Xenon 133 scanning was used in the diagnosis of inhalation injury. 
When it was combined with history it is a reliable diagnostic tool in 
identifying the inhalation injury.46 
Now we use fibre optic bronchoscope as a diagnostic tool for early 
diagnosis of inhalation injury. It can also be used as a therapeutic tool in 
giving a pulmonary lavage and removing airway plugs, deposited particulate 
matter. 
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Navar and Herndon and their colleagues emphasised  that major 
inhalation injury requires 2ml/kg/% of TBSA burnt, more fluid to maintain 
adequate hydration. 
High frequency oscillating ventilators with low peak pressure has been 
found to reduce the incidence of barotraumas and also encourage inspissated 
sputum to travel up the airway.46 
Heparin, N- acetyl cysteine, NO (nitric oxide) and bronchodilators are 
found to beneficial at least in paediatric population. 
Various improvements in the treatment of inhalation injury like 
extracorporeal membrane oxygenation devices and arterial venous CO2 
removal system are promising to reduce the mortality and morbidity 
associated with inhalation injury.         
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STUDY MATERIALS AND METHODS 
         For this study all burn patients admitted in the burn ward of Coimbatore 
Medical College, Dept. of General Surgery who fulfil the inclusion criteria 
were selected and studied. This study was conducted in a prospective 
observational study model. The study duration is about over the period of 12 
months between (Sep.2014 to Sep.2015)  
 INCLUSION CRITERIA 
o Burns 20% to 50% of total body surface area. 
o Age > 18yrs 
 EXCLUSION CRITERIA 
o Burns < 20% and > 50% excluded from the study. 
o Age < 18 yrs. Are excluded from study. 
All the burn patients above 50% are excluded from this study as they 
have high mortality rate mostly because of hypovolemia and die before 
developing septicaemia. All burn patients bellow 20% is excluded as they 
have very less chance of developing septicaemia. All paediatric age group 
patients are excluded due to very less number of patients less than 18 yrs age 
will get admitted in our burns department.   
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All the patients admitted in General Surgery Department – Burns ward in 
Coimbatore Medical College who fulfil the inclusion criteria are chosen & 
will be studied prospectively during study period. Only those who were 
admitted within first 12 hrs. of the incident were taken into account.  
 A detailed clinical history will be taken for all the patients. Thorough 
physical examination will be done for all the patients 
 Patients will be evaluated for the degree of burns, body surface area 
involved and the degree of burns. 
 Routine blood investigations, temperature of the patient, PTR, and 
blood culture sensitivity. 
 Antibiotic cover for the patients and routine dressing.  
Routine platelet count is done on 1st, 3rd, 5th & 7th day. Routine blood 
culture is sent for all the patients who fit the criteria and appropriate 
antibiotics were started based on the culture sensitivity reports. Evaluation of 
platelet count and its significance in early detection of post burn septicaemia 
will be individually  analysed for all patients. 
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RESULTS & OBSERVATIONS 
1. Trend of platelet count in survivors & non-survivors: 
No. of Patients included in the study:   157 
No. of survivors in this study             :    91 
No. of non-survivors in this study      :    66 
 
Post burn days Survivor's Group Non survivor's Group 
1st day 1.98 1.87 
3rd day 2.08 1.83 
5th day 2.17 1.67 
7th day 2.26 1.50 
 
On comparing the platelet levels in the survivors and non survivors, a 
gradual increase in trend of the platelet count was observed in the survivors 
group. A gradual decline in the platelet count was observed in the non 
survivor group. This trend was not influenced by the extent of the burn injury. 
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2. Mean platelet counts of the non-survivors and survivors : 
T-Test 
1st day Mean  S.D 
Non-survivor (n=66) 1.87 +/- .28 
Survivor (n=91) 1.98 +/- .32 
 
3rd day Mean  S.D 
Non-survivor (n=66) 1.83 +/- .42 
Survivor (n=91) 2.08 +/- .51 
 
 
5th day Mean  S.D 
Non-survivor (n=66) 1.67 +/- .51 
Survivor (n=91) 2.16 +/- .42 
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T-Test 
 
7th day Mean  S.D 
Non-survivor (n=66) 1.50 +/- .45 
Survivor (n=91) 2.26 +/- .50 
 
There is no significant difference in the platelet levels in the survivor and 
non survivor group on the first post burn day. The difference in the platelet 
levels was significant on the 5th and the 7th post burn day. 
 
3. Inhalation Injury and platelet levels: 
Total number of pts. with inhalation injury                 : 33 
Total number of pts. without  inhalation injury           : 124 
Mean platelet count among the inhalation group         :1.81 
Mean platelet count among the non-inhalation group  :2.01 
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Inhalation injury 
Non-survivor Survivor Total 
(n=66) (100%) (n=91) (100%) (n=157) (100%) 
Yes 33 50.0% 0 .0% 33 21.0% 
No 33 50.0% 91 100.0% 124 79.0% 
 
In our study of 157 patients about 33 patients had inhalation injury. On 
comparing the platelet count between the patients with inhalation injury and 
those without the inhalation injury a lower mean platelet count in those with 
the inhalation injury was observed. 
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4. Septicaemia and survivability: 
No. of survivors in this study                                                         :    91 
No. of patients with positive blood culture among survivors  :   34   
That is roughly 37.5% 
 
 
 
 
 
 
 
 
No. of non-survivors in this study                                                 :    66  
No. of patients with positive blood culture among non-survivors :  44 
That is roughly  67% 
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NON – SURVIVOR GROUP 
 
 
 
 
 
 
 
 The incidence of septicaemia in the non survivor group is higher about 
67 % when compared with the incidence of septicaemia in the survivor group 
37.5%. 
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5. Organisms causing septicaemia : 
 
            Total number of patients with positive blood culture report : 78 
 
 
 
 
 
 
 
 
 
 
 
 
Pseudomonas   29 
Klebsiella         22 
Staph. Aureus   18 
Proteus            12 
E.coli                12 
Acinetobacter  8 
Others             15 
Mixed 31 
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Organisms Causing Septicaemia  
 
 
 
 
 
 
 
The most common organism in causing septicaemia in the burn 
patients is Pseudomonas sp. Others organisms which caused septicaemia are 
Klebsiella, E.coli, Proteus, Acinetobacter sp., Staphylococcus aureus. 
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6. % TBSA burnt & Survivability: 
 
 
 
 
 
 
 
 
 
 
 
 
 
The survivability was higher with younger age and with lower % 
TBSA burnt. 
% of TBSA 20-29 30-39 40-50 
Died 6 11 49 
Survived  32 29 30 
Total 38 40 79 
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7. Degree of Burns and Survivor 
 
Degree of burn 
Non-survivor Survivor  
 
(n=66) (100%) (n=91) (100%)   
1 0 .0% 28 30.8%   
 2 50 75.8% 61 67.0%   
3 16 24.2% 2 2.2%   
 
 
 
 
 
 
 
 
The survival was higher in the 1st & 2nd degree burns when compared with 
the 3rd degree burns. 
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8. Age distribution among burns patients: 
Age 10-19 20- 29 30-39 40-49 50-59 60-69 > 70 
Male 12 61 58 47 20 9 4 
Female 15 69 42 23 8 5 13 
 
 
 
 
 
 
 
 
 
The burn injury is common in the age group of 20 to 45 yrs., it is more 
common in males than in females.  
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DISCUSSION 
There are many studies done with the aim of early identification of 
septicaemia. Platelet index is an important lab finding that can be used in the 
diagnosis of sepsis. It is established that in sepsis patients with greater than 
18 % PDW have a greater risk of death. In this study we try to find the 
relation between the platelet count and prognosis in septicaemia.  
On comparing the platelet levels in the survivors and non survivors a 
gradual increase in trend of the platelet count was observed in the survivors 
group and a gradual decline in the platelet count was observed in the non 
survivor group. This trend was not influenced by the extent of the burn injury. 
Though the exact mechanism of thrombocytopenia in septicaemia is 
uncertain there are a few theories that try to explain this fall in the platelet 
levels in septicaemia. Its rapid onset suggests that there is increased platelet 
destruction, a mechanism that is supported by the results of platelet survival 
studies reported by others previously. Another possible mechanism is that the 
increased rate of platelet destruction in patients with septicaemia may result 
from either overt or possible subclinical DIC. 
In our study we observed that there is no significant difference in the 
platelet levels in the survivor and non survivor group on the first post burn 
day but. The difference in the platelet levels was significant on the 5th and the 
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7th post burn day. This platelet count was the lowest in the non survivor 
group just before their death. This fall in the platelet levels was steepest prior 
to death.  
  There are many factors that can influence the platelet count other than 
septicaemia in the burn patients. One of the most important is inhalation 
injury. With the early identification and prompt management of septicaemia, 
the proportion of death that is caused by inhalation injury has gone up. In our 
study of 157 patients about 33 patients had inhalation injury. All the patients 
with inhalation injury succumbed to it with in 5th post burn day despite early 
intubation and ventilator management. On comparing the platelet count 
between the patients with inhalation injury and those without the inhalation 
injury a lower mean platelet count in those with the inhalation injury was 
observed. 
The incidence of septicaemia in the non survivor group is higher about 
67 % when compared with the incidence of septicaemia in the survivor group 
37.5%. This cause of septicaemia may be due to direct invasion of the 
organisms from the burn wound or also due to pulmonary infection, urinary 
tract infection, etc. The most common organism in causing septicaemia in the 
burn patients is Pseudomonas sp. Others organisms which caused septicaemia 
are Klebsiella, E.coli, Acinetobacter sp., Staphylococcus aureus. It is 
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generally observed that the mortality rate among those with Staphylococcus 
aureus was comparatively higher when compared with other organisms. 
The survival was higher in the 1st & 2nd degree burns when compared 
with the 3rd degree burns. Also the survivability was higher with younger age 
and with lower % TBSA burnt. The burn injury is common in the age group 
of 20 to 45 yrs., it is more common in males than in females.  
Skin a highly dynamic organ, its function as anatomical barrier can be 
best observed from the burns injury. In this study we found the correlation 
between the platelet count and its usefulness in predicting septicaemia in 
burns patients. Once patient undergoes septicaemia, it can affect almost all 
organ systems of body inducing systemic inflammatory response syndrome 
followed by multiple organ dysfunction syndrome with death as an ultimate 
effect. The routine monitoring of platelets will help in the early identification 
of septicaemia thus giving us an early start in the management of septicaemia 
and potentially saving the patient’s life. 
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CONCLUSIONS 
1. On comparing the platelet levels in the survivors and non survivors an 
gradual increase in trend of the platelet count was observed in the 
survivors group a gradual decline in the platelet count was observed in 
the non survivor group. This trend was not influenced by the extent of 
the burn injury. 
2. There is no significant difference in the platelet levels in the survivor 
and non survivor group on the first post burn day. The difference in the 
platelet levels was significant on the 5th and the 7th post burn day. 
3. In our study of 157 patients about 33 patients had inhalation injury. On 
comparing the platelet count between the patients with inhalation 
injury and those without the inhalation injury a lower mean platelet 
count in those with the inhalation injury was observed. 
4. The incidence of septicaemia in the non survivor group is higher about 
67 % when compared with the incidence of septicaemia in the survivor 
group 37.5%. 
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5. The most common organism in causing septicaemia in the burn 
patients is Pseudomonas sp. Others organisms which caused 
septicaemia are Klebsiella, E.coli, Acinetobacter sp., Staphylococcus 
aureus. 
6. The survival was higher in the 1st & 2nd degree burns when compared 
with the 3rd degree burns. Also the survivability was higher with 
younger age. 
7. The burn injury is common in the age group of 20 to 45 yrs., it is more 
common in males than in females.  
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MASTER CHART 
S.no. Ip.No Name Age Sex DoA 
% of 
TBSA 
Degree 
 of burn 
Inhalation 
 injury 
Platelets x 10 9 / L 
DoD Fate 
1st 
day 
3rd 
day 
5th 
day 
7th 
day 
1 58084 Selvaraj 30 M 12.9.14 50 1 No 1.98 1.92 1.8 1.75 19.9.14 Discharged 
2 58334 Murugan 35 M 13.9.14 20 2 No 2.3 2.35 17.9.14 Discharged 
3 58652 Suresh 20 M 14.9.14 30 2 No 2.32 2.77 2.58 2.23 22.9.14 Discharged 
4 58692 Budda Dev 23 M 14.9.14 20 2 Yes 1.82 1.63 17.9.14 Died 
5 59467 Kannagi 18 F 17.9.14 30 2 Yes 1.95 1.8 1.93 1.4 24.9.14 Died 
6 59516 Ragu 39 M 17.9.14 20 2 No 2.03 2.1 2.4 22.9.14 Discharged 
7 59598 Hariprakash 31 M 18.9.14 30 2 No 2.35 2.52 2.58 2.24 26.9.14 Discharged 
8 59814 Muthuraman 45 M 19.9.14 40 2 Yes 1.8 
   
20.9.14 Died 
9 59974 Gomathi 27 F 19.9.14 35 2 Yes 1.92 1.85 1.65 25.9.14 Died 
10 60252 Saraswathi 65 F 20.9.14 20 2 No 2.2 2.03 1.87 25.9.14 Discharged 
11 60264 Selvaraj 58 M 20.9.14 40 2 No 1.91 1.65 1.42 1.15 4.10.14 Died 
12 60204 Eswari 30 F 21.9.14 20 2 Yes 1.7 21.9.14 Died 
13 60827 Sumathi 25 F 23.9.14 25 2 No 2.01 2.35 2.5 
 
28.9.14 Discharged 
14 61163 Biploray 19 M 24.9.14 25 1 No 2.13 2.24 28.9.14 Discharged 
15 61279 Karthikayan 26 M 26.9.14 35 2 No 1.8 1.95 2.38 7.10.14 Discharged 
16 61852 Karupannan 40 M 27.9.14 20 2 No 1.8 1.98 2.34 2.57 8.10.14 Discharged 
17 62031 Kumar 37 M 28.9.14 45 2 No 1.82 1.92 1.98 2.24 21.10.14 Discharged 
18 63794 Saraswathi 55 F 6.10.14 45 2 No 1.85 1.78 1.65 1.4 18.10.14 Died 
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S.no. Ip.No Name Age Sex DoA 
% of 
TBSA 
Degree 
 of burn 
Inhalation 
 injury 
Platelets x 10 9 / L 
DoD Fate 
1st 
day 
3rd 
day 
5th 
day 
7th 
day 
19 63834 Kavitha 27 F 7.10.14 45 2 Yes 1.88 1.82 1.62 11.10.14 Died 
20 65925 Murugan 65 M 15.10.14 40 2 No 1.92 2.13 2.24 2.57 23.10.14 Discharged 
21 66373 Ponnuchami 39 M 17.10.14 40 2 No 2.01 2.16 2.1 2.4 29.10.14 Discharged 
22 66676 Anand 36 M 19.10.14 20 2 No 2.31 2.28 22.10.14 Discharged 
23 66756 Gunasekharan 35 M 20.10.14 20 1 No 2.31 2.58 22.10.14 Discharged 
24 66840 Maragatham 20 F 20.10.14 50 2 No 2.03 1.85 1.72 25.10.14 Died 
25 66922 Kavitha 28 F 21.10.10 36 2 No 1.95 2.01 2.24 2.31 1.11.15 Discharged 
26 67030 Shankaralingam 46 M 21.10.14 20 1 No 1.81 1.72 23.10.14 Discharged 
27 67144 Amutha 49 F 22.10.14 50 2 Yes 1.87 23.10.14 Died 
28 67149 Suresh 30 M 22.10.14 30 2 Yes 1.94 23.10.14 Died 
29 68070 Jayakodi 25 F 24.10.14 45 2 No 1.95 1.85 1.72 
 
30.10.14 Died 
30 68153 Sumithra 26 F 25.10.14 50 2 Yes 1.85 1.75 1.45 29.10.14 Died 
31 68636 Padmavathi 20 F 30.10.14 50 1 No 1.85 2.02 2.1 2.4 11.11.14 Discharged 
32 71484 Maharaja 45 M 8.11.14 35 2 No 1.92 1.98 2.21 2.2 5.12.14 Discharged 
33 71794 BeerMuhamed 31 M 10.11.14 40 1 No 2.1 2.24 2.43 2.39 19.11.14 Discharged 
34 72720 Padmavathi 20 F 13.11.14 50 1 No 1.96 1.93 2.21 2.35 19.11.14 Discharged 
35 73019 Rajeshkannan 40 M 15.11.14 55 2 No 1.87 1.8 1.72 1.45 27.11.14 Died 
36 73417 Jaganathan 52 M 16.11.14 36 2 Yes 1.82 17.11.14 Died 
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37 71891 Lakshmi 57 F 16.11.14 30 2 Yes 1.9 17.11.14 Died 
38 73715 Manimagalai 22 F 17.11.14 27 3 No 1.75 1.8 1.61 1.3 28.11.14 Died 
39 73719 Ashok Kumar 35 M 17.11.14 40 1 No 2.15 2.35 2.42 2.56 28.11.14 Discharged 
40 73714 Suresh 28 M 17.11.14 20 1 No 2.15 2.15 2.32 22.11.14 Discharged 
41 74239 Praveen 45 M 19.11.14 50 2 No 1.82 1.84 2.5 11.12.14 Discharged 
42 74239 Karthick 24 M 19.11.14 30 1 No 1.84 2.04 
  
22.11.14 Discharged 
43 76092 Omarsaleem 18 M 27.11.14 20 1 No 1.72 2.01 2.24  2.12.14 Discharged 
44 76370 Shankar 20 M 28.11.14 35 2 No 2.1 2.15 2.01 2.2 29.12.14 Discharged 
45 78559 Sudha 28 F 8.12.14 38 2 No 1.87 1.8 1.7 25.12.14 Discharged 
46 78607 Raju 58 M 8.12.14 40 2 Yes 1.81 8.12.14 Died 
47 79481 Kannamal 28 F 11.12.14 40 2 No 1.87 1.8 1.74 1.6 20.12.14 Died 
48 80059 Nandhagopal 26 M 14.12.14 50 2 No 1.91 1.71 1.74 18.12.14 Died 
49 80299 Ajmal Kahn 48 M` 15.12.14 20 2 No 2.3 2.14 2.2 2.42 30.12.14 Discharged 
50 82045 Gopi 23 M 23.12.14 50 3 No 2.01 1.85 1.61 
 
28.12.14 Died 
51 82641 Jesuraj 54 M 25.12.14 40 3 No 1.81 1.54 1.45 30.12.14 Died 
52 82680 Thangamani 27 F 25.12.14 30 2 Yes 1.75 1.82 26.12.14 Died 
53 83090 Ambika  40 F 27.12.14 30 1 No 1.87 1.95 2.17 2.35 5.1.15 Discharged 
54 83525 Venkateshwari 20 F 29.12.14 50 3 No 2.14 1.87 1.95 1.8 8.1.15 Died 
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55 1136 Senthilkumar 29 M 5.1.15 30 2 No 1.99 2.01 2.16 2.36 28.1.15 Discharged 
56 2786 Velathal 90 F 13.1.15 50 2 No 1.84 1.9 1.75 1.6 20.1.15 Died 
57 3082 Thulasiammal 80 F 14.1.15 40 2 No 1.98 1.84 1.72 1.61 24.1.15 Died 
58 3306 Sandhaya 22 F 15.1.15 20 1 No 2.1 1.95 2.2 18.1.15 Discharged 
59 3357 Nagammal 65 F 15.1.15 20 1 No 2.2 2.06 2.3 20.1.15 Discharged 
60 4030 Subbathal 80 F 19.1.15 30 2 Yes 1.81 1.94 
  
21.1.15 Died 
61 4670 Vijayakumar 48 M 21.1.15 25 1 No 2.1 2.05 2.15 24.1.15 Discharged 
62 5477 Pushpam 57 F 24.1.15 20 2 Yes 1.79 1.73 1.8 28.1.15 Died 
63 5696 Aruchami 40 M 25.1.15 40 2 No 2.2 2.1 2.34 2.4 10.2.15 Discharged 
64 6149 Bakyam 32 F 27.1.15 20 2 No 2.1 2.15 2.2 2.2.15 Discharged 
65 6238 Mushthak 18 M 27.1.15 20 2 No 2.15 2.1 2.3 2.2.15 Discharged 
66 6543 Lakshmi 30 F 29.1.15 50 2 Yes 1.87 29.1.15 Died 
67 6915 Murugan 50 M 30.1.15 50 2 No 1.98 1.89 1.9 2.2 17.2.15 Discharged 
68 6930 Shanmugam 50 M 30.1.15 30 2 No 1.87 1.7 1.95 2.1 13.2.15 Discharged 
69 7295 Sangeetha 40 F 1.2.15 50 2 No 1.82 1.98 1.87 1.61 7.2.15 Died 
70 7567 Karnanithi 48 M 2.2.15 30 2 Yes 1.82 2.2.15 Died 
71 7769 Saraswathi  70 F 2.2.15 35 2 No 1.74 1.64 1.4 0.9 16.2.15 Died 
72 7978 Kalaimani 37 F 11.2.15 35 2 No 2.12 2.1 2.15 2.2 27.2.15 Discharged 
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73 11936 Sudha 23 F 18.2.15 50 2 No 1.87 1.99 2.01 2.2 28.2.15 Discharged 
74 13862 Mahamani 46 M 25.2.15 45 2 No 2.03 1.87 1.62 3.3.15 Died 
75 13570 Bhakiyalakshmi 29 F 25.2.15 40 2 Yes 1.61 1.52 27.2.15 Died 
76 13567 Mahalakshmi 46 F 25.2.15 40 3 No 1.59 1.4 27.2.15 Died 
77 13893 Vasanthi 35 F 26.2.15 20 1 No 2 2.1 28.2.15 Discharged 
78 17329 Sangeetha 17 F 11.3.15 50 2 No 2.05 1.85 1.61 
 
18.3.15 Died 
79 18009 Anand 24 M 14.3.15 50 3 No 2.01 1.71 1.5 18.3.15 Died 
80 18067 Nagammal 70 F 14.3.15 50 3 No 2.01 1.6 1.52 18.3.15 Died 
81 18431 Senthal 35 F 16.3.15 50 2 No 1.98 1.88 1.8 1.4 31.3.15 Died 
82 18569 Perumal 75 M 16.3.15 50 2 No 1.98 1.9 18.3.15 Died 
83 19442 Sreeram 36 M 20.3.15 30 2 No 2.01 2.03 2.06 2.11 30.3.15 Discharged 
84 19545 Mohamed 36 M 21.3.15 25 1 No 2.03 2.05 2.2 24.3.15 Discharged 
85 20778 Rajalakshmi 37 F 26.3.15 45 2 Yes 1.85 27.3.15 Died 
86 20925 Sangeetha 19 F 26.3.15 40 2 No 1.61 1.59 1.4 1.1 7.4.15 Died 
87 22140 Balakrisnan 67 M 3.4.15 50 3 Yes 1.5 3.4.15 Died 
88 23033 Shankar 23 M 5.4.15 40 2 No 2.01 1.76 2.1 2.5 18.4.15 Discharged 
89 23373 Pranesh 28 M 6.4.15 35 2 No 2 1.87 2 2.1 20.4.15 Discharged 
90 23515 AshrafAli 45 M 7.4.15 25 2 No 1.96 2.04 1.9 11.4.15 Died 
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91 23576 Shakthivel  40 M 7.4.15 30 2 No 2.03 2.04 2.06 2.11 20.4.15 Discharged 
92 23999 Masanam 23 M 9.4.15 40 2 No 2.01 1.98 1.76 2.1 21.4.15 Discharged 
93 26321 Marimuthu 30 M 19.4.15 20 2 No 2.03 2.06 1.99 1.98 29.4.15 Discharged 
94 26834 Rajenthran 38 M 21.4.15 50 3 No 1.4 22.4.15 Died 
95 27032 Rajan 22 M 22.4.15 50 2 No 1.98 1.99 2 2.04 15.5.15 Discharged 
96 27031 Sivan 21 M 22.4.15 50 2 No 1.97 1.99 1.89 2.01 15.5.15 Discharged 
97 27033 Sivashankar 21 M 22.4.15 40 2 No 2.01 1.86 1.77 15.5.15 Discharged 
98 27030 Chandran 32 M 22.4.15 50 2 No 1.98 1.99 2.05 2.15 15.5.15 Discharged 
99 28177 Sathya 26 F 27.4.15 35 2 No 2.01 2.1 1.98 2.01 10.5.15 Discharged 
100 27799 Kanagalakshmi  23 F 26.4.15 50 3 Yes 1.86 1.8 1.89 1.61 27.5.15 Died 
101 26992 Alex 19 M 23.4.15 30 2 No 2 2.11 2.26 2.5 30.4.15 Discharged 
102 29497 Devi 26 F 3.5.15 50 3 No 2.04 2 1.85 1.61 9.5.15 Died 
103 28661 Lakshmi 43 F 30.4.15 20 2 No 2.03 2.06 2.1 2.11 7.5.15 Discharged 
104 29433 Shanmugapriya 18 F 3.5.15 50 3 No 2.05 2 1.85 
 
8.5.15 Died 
105 30156 Raja 28 M 6.5.15 30 2 No 2 2.06 2.11 11.5.15 Discharged 
106 30998 Selvi 48 F 9.5.15 50 2 No 2.37 2.2 2.11 2.01 20.5.15 Died 
107 31019 Ranganathan 52 M 9.5.15 30 2 No 2.01 2.11 2.18 2.3 25.5.15 Discharged 
108 31051 Palanisamy 48 M 10.5.15 35 2 No 2.4 2.41 2.58 2.59 25.5.15 Discharged 
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109 33131 Vani 31 F 15.5.15 35 2 No 1.98 2.01 2.04 2.05 23.5.15 Discharged 
110 33619 Priyadharshini 25 F 21.5.15 20 1 No 2.01 2.06 2.15 26.5.15 Discharged 
111 33866 Sangeetha 26 F 22.5.15 45 2 No 1.98 1.99 1.99 2 3.6.15 Discharged 
112 34779 Muthulakshmi 70 F 26.5.15 50 2 No 2.05 1.85 29.5.15 Died 
113 35953 Kupammal 65 F 29.5.15 50 2 No 2.04 1.8 1.75 1.65 7.6.15 Died 
114 36481 Chandrakala 38 F 31.5.15 40 2 Yes 1.6 1.51 1.49 
 
2.5.15 Died 
115 36707 Yaskin Ali 30 M 1.6.15 25 1 No 2.01 2.06 2.1 6.6.15 Discharged 
116 36799 Mary 32 F 2.6.15 50 2 Yes 1.85 1.82 1.71 4.6.15 Died 
117 37029 Aravind 26 M 3.6.15 30 2 No 2.03 2.06 2.15 2.3 10.6.15 Discharged 
118 37070 Jayaraman 65 M 3.6.15 20 2 No 2.01 2.11 2.35 2.61 9.6.15 Discharged 
119 37325 Sampathkumar 29 M 4.6.15 50 3 No 2.04 1.85 1.61 1.55 10.6.15 Died 
120 37589 Nataraj 46 M 5.6.15 25 1 No 2.01 2.06 2.11 10.6.15 Discharged 
121 38128 Prema 22 F 7.6.15 50 2 Yes 1.74 1.52 10.6.15 Died 
122 36961 Ambikawathy 29 F 2.6.15 30 1 No 2.01 2.07 2.1 2.41 8.6.15 Discharged 
123 38390 Hazzinabanu 24 F 8.6.15 35 2 No 2.41 2.61 2.63 2.65 15.6.15 Discharged 
124 38833 Poongodi 32 F 9.6.15 45 2 No 1.98 1.99 2 2.02 21.6.15 Discharged 
125 39849 Saranya 26 F 14.6.15 40 1 No 2.01 2.13 17.6.15 Discharged 
126 41617 Sandhya 21 F 21.6.15 50 2 Yes 1.92 1.85 23.6.15 Died 
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127 42221 Neelaveni 29 F 21.6.15 50 2 Yes 1.93 1.76 24.6.15 Died 
128 45042 Durga 27 F 4.7.15 50 1 No 1.98 1.99 2 2.08 17.7.15 Discharged 
129 46545 Subash 22 M 10.7.15 35 2 No 2.01 2.15 2.23 2.43 23.7.15 Discharged 
130 46762 Arunpandiyan 20 M 13.7.15 40 2 No 2 2.11 2.14 2.41 23.7.15 Discharged 
131 47304 Mounambika 38 F 14.7.15 45 2 Yes 1.95 1.87 1.065 18.7.15 Died 
132 45980 Manikandan 20 M 9.7.15 45 1 No 1.99 2.32 2.44 
 
11.7.15 Discharged 
133 50144 Vanitha 30 F 25.7.15 45 2 No 1.97 2.44 2.51 2.61 10.8.15 Discharged 
134 50428 Malar 28 F 27.7.15 50 2 Yes 1.87 1.75 1.61 2.8.15 Died 
135 50856 Chandrasekar 46 M 28.7.15 45 2 No 2.03 1.99 1.71 1.54 13.8.15 Died 
136 51038 Ashwinkumar 23 M 29.7.15 20 2 No 2.01 2.06 2.12 2.8.15 Discharged 
137 51585 Asha 26 F 30.7.15 30 1 No 1.98 2 2.05 4.8.15 Discharged 
138 51665 Paulpandy 37 M 1.8.15 25 2 No 1.99 2.01 2.11 2.15 7.8.15 Discharged 
139 51903 Revathy 26 F 2.8.15 25 2 No 2 2.01 2.23 2.32 10.8.15 Discharged 
140 52674 Thenmozli 27 F 5.8.15 45 2 Yes 1.74 
   
6.8.15 Died 
141 53022 Shanmugam 33 M 6.8.15 25 3 No 2.11 2.13 2.2 2.22 15.8.15 Discharged 
142 53020 Malakodi 55 F 6.8.15 21 2 No 1.97 2.01 2.13 2.14 15.8.15 Discharged 
143 53224 Anegha 40 F 7.8.15 40 2 No 2.32 2.3 2.58 2.6 8.9.15 Discharged 
144 53312 Subramani 65 M 8.8.15 30 2 No 2.03 2.07 2.07 2.11 12.8.15 Discharged 
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145 53532 Chitra 28 F 9.8.15 45 3 No 1.9 1.89 1.99 2.01 25.8.15 Discharged 
146 53599 Paramasivam 40 M 9.8.15 35 2 No 2 2.03 2.13 2.32 13.8.15 Discharged 
147 53685 Surya 32 M 10.8.15 20 1 No 2.03 2.05 13.8.15 Discharged 
148 54427 Radha 31 F 13.8.15 45 1 No 2.16 2.15 2.16 20.8.15 Discharged 
149 54432 Rajeshwari 27 F 13.8.15 20 2 No 2.01 2.06 2.13 18.8.15 Discharged 
150 54955 Mahabu 45 F 15.8.15 45 3 Yes 1.76 
   
16.8.15 Died 
151 55154 Suseela 80 F 16.8.15 30 2 No 1.6 1.59 1.55 20.8.15 Died 
152 55650 Saiprasanth 18 M 17.8.15 37 2 Yes 1.85 1.5 20.8.15 Died 
153 56193 Neela 28 F 19.8.15 40 2 No 2.01 2.11 2.21 2.26 30.8.15 Discharged 
154 56731 Raju 52 M 21.8.15 20 3 Yes 1.75 21.8.15 Died 
155 56762 Shayamprasath 21 M 21.8.15 20 2 No 2.01 2.04 2.15 25.8.15 Discharged 
156 56796 Hariharan 18 M 21.8.15 50 3 Yes 1.78 21.8.15 Died 
157 57422 Vijayakumar 56 M 23.8.15 45 1 No 1.98 1.99 26.8.15 Discharged 
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APPENDIX – II 
PROFORMA 
1. NAME: 
2. AGE/SEX: 
3. IP.NO.: 
4. BRIEF HISTORY: 
5. CO-MORBID ILLNESS: 
6. MARITAL STATUS: 
7. GENERAL EXAMINATION: 
8. VITALS: 
9. SYSTEMIC EXAMINATIONS: 
10. WOUND EXAMINATION: 
11. EXAMINATION FOR INHALATION INJURY: 
12. BLOOD INVESTIGATIONS: 
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APPENDIX – III 
STATEMENT OF CONSENT 
 
I, _____________________, do hereby volunteer and consent to 
participate in this study being conducted by Dr. T.G.VASANTH RAJA.on 
“PLATELET COUNT AS A PROGNOSTIC INDICATOR IN BURN 
SEPTICAEMIA” I have read and understood the consent form / or it has been 
read and explained to me in my own language. The study has been fully 
explained to me, and I may ask questions at any time. 
 
Signature / Left Thumb Impression of the Volunteer Date:          Place: 
 
Signature and Name of witness     Date:          Place: 
 
Signature of the investigator: 
 
Name of the investigator:  
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xg;g[jy; gotk; 
 
bgah;   : 
ghypdk;  : 
Kfthp   :     taJ    : 
 
muR nfhit kUj;Jtf; fy;Y}hpapy;/ bghJ mWit rpfpr;ir 
Jiwapy;/ gl;l nkw;gog;g[ gapYk; khzth; T.G. tre;j;uh$h mth;fs; 
nkw;bfhs;Sk; "PLATELET COUNT AS A PROGNOSTIC INDICATOR IN 
BURN SEPTICEMIA" vd;w nrhjidapd; bra;Kiw kw;Wk; midj;J 
tpgu';fisa[k; nfl;Lf;bfhz;lJld;/ vdJ midj;J re;njf';fisa[k; 
bjspt[g;gLj;jpf;bfhz;nld; vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;. 
,e;j Ma;tpy; vd;Dila midj;J tpgu';fSk; 
ghJfhf;fg;gLtJld;/ ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; 
vdf;F ve;j Ml;nrgida[k; ,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. 
ve;j neuj;jpYk; ,e;j Ma;tpy; ,Ue;J tpyfpf;bfhs;s vdf;F chpik 
cz;L vd;gija[k; mwpntd;.  
 
,lk;  : 
njjp  :      ifbahg;gk; /   nuif 
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APPEDIX - IV 
LIST OF ABBREVIATIONS 
 
Multiple organ dysfunction syndrome  MODS  
Total body surface area   TBSA  
Platelet derived growth factor  PDGF 
Platelet activating factor              PAF 
Platelet count               PC 
 Mean platelet volume             MPV 
Platelet distribution width             PFW 
Thrombocytocrit  Tc 
Patient  Pt 
Years Yrs 
Fibrinopeptide A              FPA 
  
Nitric oxide               NO 
 
Carbon dioxide              CO2 
